rs142851023

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 2P and 7B. PM2BP4_ModerateBP6BS1

The NM_004369.4(COL6A3):​c.8009C>T​(p.Ala2670Val) variant causes a missense change. The variant allele was found at a frequency of 0.000658 in 1,613,318 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A2670A) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00061 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00066 ( 1 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

5
3
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:3

Conservation

PhyloP100: 5.67
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.11057228).
BP6
Variant 2-237340907-G-A is Benign according to our data. Variant chr2-237340907-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 128822.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=4}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000611 (93/152302) while in subpopulation AMR AF= 0.00189 (29/15306). AF 95% confidence interval is 0.00136. There are 0 homozygotes in gnomad4. There are 66 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.8009C>T p.Ala2670Val missense_variant Exon 38 of 44 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.7391C>T p.Ala2464Val missense_variant Exon 37 of 43 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.6188C>T p.Ala2063Val missense_variant Exon 35 of 41 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.8009C>T p.Ala2670Val missense_variant Exon 38 of 44 1 NM_004369.4 ENSP00000295550.4 P12111-1

Frequencies

GnomAD3 genomes
AF:
0.000605
AC:
92
AN:
152184
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000647
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.000622
AC:
156
AN:
250794
Hom.:
0
AF XY:
0.000657
AC XY:
89
AN XY:
135512
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00121
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000761
Gnomad SAS exome
AF:
0.000328
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000697
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000663
AC:
968
AN:
1461016
Hom.:
1
Cov.:
33
AF XY:
0.000652
AC XY:
474
AN XY:
726666
show subpopulations
Gnomad4 AFR exome
AF:
0.000598
Gnomad4 AMR exome
AF:
0.00105
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000605
Gnomad4 SAS exome
AF:
0.000151
Gnomad4 FIN exome
AF:
0.0000187
Gnomad4 NFE exome
AF:
0.000726
Gnomad4 OTH exome
AF:
0.000663
GnomAD4 genome
AF:
0.000611
AC:
93
AN:
152302
Hom.:
0
Cov.:
32
AF XY:
0.000886
AC XY:
66
AN XY:
74458
show subpopulations
Gnomad4 AFR
AF:
0.000313
Gnomad4 AMR
AF:
0.00189
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000647
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.000661
Hom.:
1
Bravo
AF:
0.000827
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00182
AC:
7
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000581
AC:
5
ExAC
AF:
0.000601
AC:
73
Asia WGS
AF:
0.00115
AC:
4
AN:
3478
EpiCase
AF:
0.000872
EpiControl
AF:
0.00107

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2Benign:1
Jan 20, 2017
Eurofins Ntd Llc (ga)
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

COL6A3: BP4 -

Oct 23, 2013
Genetic Services Laboratory, University of Chicago
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Bethlem myopathy 1A Benign:2
Jan 15, 2024
Medical Molecular Genetics Department, Human Genetics and Genome Research Division, National Research Centre
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Jan 31, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Ullrich congenital muscular dystrophy 1A;C4225336:Dystonia 27;CN029274:Bethlem myopathy 1A Uncertain:1
May 23, 2017
Fulgent Genetics, Fulgent Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Uncertain:1
Apr 04, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Variant summary: COL6A3 c.8009C>T (p.Ala2670Val) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00062 in 250794 control chromosomes (gnomAD). c.8009C>T has been reported in the literature in individuals affected with neuromuscular disorders without strong evidence of causality (e.g. Ankala_2015, Nallamilli_2018, Meinlke_2020, Marinella_2022). These reports do not provide unequivocal conclusions about association of the variant with Ullrich Congenital Muscular Dystrophy 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 25380242, 30564623, 31862442, 36498898). ClinVar contains an entry for this variant (Variation ID: 128822). Based on the evidence outlined above, the variant was classified as uncertain significance. -

COL6A3-related disorder Uncertain:1
Nov 29, 2023
PreventionGenetics, part of Exact Sciences
Significance: Uncertain significance
Review Status: no assertion criteria provided
Collection Method: clinical testing

The COL6A3 c.8009C>T variant is predicted to result in the amino acid substitution p.Ala2670Val. This variant has been reported in multiple patients with muscular disorders; however the pathogenicity of this change has not been elucidated with functional or segregation studies (Ankala et al. 2015. PubMed ID: 25380242; Nallamilli et al. 2018. PubMed ID: 30564623; Meinke et al. 2019. PubMed ID: 31862442; Kars et al. 2021. PubMed ID: 34426522). This variant is reported in 0.12% of alleles in individuals of Latino descent in gnomAD and 174 total heterozygotes. This is a higher frequency than other known pathogenic variants in the COL6A3 gene. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
22
DANN
Benign
0.72
DEOGEN2
Benign
0.36
.;T;.;T;.
Eigen
Uncertain
0.28
Eigen_PC
Benign
0.13
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.89
D;D;D;D;.
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.11
T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Pathogenic
3.1
.;M;.;.;.
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-2.2
N;N;N;.;N
REVEL
Pathogenic
0.73
Sift
Uncertain
0.0070
D;D;D;.;D
Sift4G
Pathogenic
0.0
D;D;D;D;D
Polyphen
0.97
D;D;.;.;D
Vest4
0.65
MVP
0.50
MPC
0.15
ClinPred
0.11
T
GERP RS
4.3
Varity_R
0.12
gMVP
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142851023; hg19: chr2-238249550; COSMIC: COSV55092132; COSMIC: COSV55092132; API